Advanced Therapies USA 2026

A two-day congress and exhibition for the advanced therapies (ATMP) sector, run by Terrapinn across eight content tracks with built-in one-to-one networking. The organiser states 1,200+ attendees, 200+ speakers and 50+ exhibitors. One track, Supply Chain & Logistics, covers logistics, transportation, distribution and cold chain, plus patient experience and point-of-care delivery.

Cell and gene therapies are among the most demanding cold-chain payloads, often moved cryopreserved and tied to a single patient. The supply-chain track is where therapy developers and logistics providers discuss how those products reach treatment centres; the rest of the programme shows where commercial volumes are heading.

Leaders and senior executives of ATMP companies, plus pharma, biotech, start-ups, researchers, clinicians, academics, HTAs, payers and regulators, with logistics and service providers exhibiting.